Trial intelligence / Profile preview

Tolerability of Alacaftadine vs Naphazoline/Pheniramine in Allergic Conjunctivitis

NCT01390961Phase 4Unknown

Sponsor
Milton M. Hom, OD, FAAO
Start
Aug 2011
Primary completion
Dec 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of alcaftadine in allergic conjunctivitis (AC), sponsored by Milton M. Hom, OD, FAAO. Status: unknown.

02

Drugs

alcaftadine
03

Conditions

allergic conjunctivitis (AC)

Beyond the preview

Go deeper on NCT01390961.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01390961.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call